Metvix

Methyl aminolevulinate, the active ingredient in Metvix, is a photosensitizer presented as a cream for topical use. It is employed to treat actinic keratosis, a precancerous skin lesion that commonly occurs on sun‑exposed areas in adult patients.

GNH USA supplies Metvix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Clients benefit from reliable logistics, batch traceability, and responsive technical support throughout the supply chain.

Metvix is used in the management of actinic keratosis, a precancerous skin condition treated with photodynamic therapy.

- Actinic keratosis (single lesions): targeted removal of dysplastic keratinocytes and lesion clearance. - Actinic keratosis (multiple lesions): field‑directed therapy to treat extensive areas of sun‑damaged skin. - Actinic keratosis (post‑treatment): reduces recurrence risk by eliminating residual atypical cells.

Metvix may cause a range of local skin reactions following application and light activation.

Common Side Effects: - Erythema: redness at the treatment site. - Edema: mild swelling of the skin. - Crusting: formation of a dry scab over the lesion. - Pain: discomfort during or after illumination. - Itching: sensation of itchiness on the treated area. - Burning: transient heat sensation.

Serious or Rare Side Effects: - Ulceration: development of an open sore at the site. - Infection: bacterial colonisation of damaged skin. - Severe photosensitivity reaction: exaggerated response to light exposure. - Scarring: permanent tissue changes after healing. - Allergic contact dermatitis: immune‑mediated skin rash. - Systemic hypersensitivity: rare systemic allergic response.

When using Metvix, several precautions should be observed to ensure safety and optimal outcomes.

- Sun exposure: avoid direct sunlight on treated area for at least 48 hours after illumination. - Lesion selection: confirm diagnosis of actinic keratosis before treatment. - Pain management: monitor patient discomfort and provide appropriate analgesia if needed. - Hypersensitivity: discontinue use if severe allergic reaction occurs. - Storage: Store at room temperature: keep in original container, protect from light and moisture.

Metvix can interact with other agents that affect photosensitivity or skin healing.

Major Interactions (Avoid): - Systemic photosensitizers (e.g., porfimer sodium): may amplify light‑induced damage. - Tetracycline antibiotics: increase photosensitivity risk. - Oral retinoids (e.g., isotretinoin): enhance skin irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may alter healing response. - Immunosuppressants: could affect lesion clearance efficacy.